Cabergoline: an effective treatment for conception in prolactinoma

Background and objective: Prolactinoma is an uncommon cause of amenorrhea and subfertility in females. When diagnosed, symptoms resolve with medical treatment in 90% of the cases. Conception and uneventful pregnancy, however, remain a big challenge in these patients. The objective of this study was...

Full description

Saved in:
Bibliographic Details
Published in:BioMedica Vol. 38; no. 3; pp. 163 - 166
Main Authors: Zahra Safdar, Omair Afzal, Rabia Nafees, Nabeel Choudhary
Format: Journal Article
Language:English
Published: Discover STM Publishing Ltd 30-09-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background and objective: Prolactinoma is an uncommon cause of amenorrhea and subfertility in females. When diagnosed, symptoms resolve with medical treatment in 90% of the cases. Conception and uneventful pregnancy, however, remain a big challenge in these patients. The objective of this study was to determine the therapeutic effectiveness of Cabergoline for conception in female patients with prolactinoma. The duration for restoration of menstruation, spontaneous conception, and outcomes of pregnancy were recorded over a period of 1 year in relation to prolactin level estimation. Methods: This prospective study was carried over a period of 2 years from December, 2019 to December, 2021. A total of 696 female patients of reproductive age, diagnosed with prolactinomas, were included and randomly divided into 2 groups; A (Cabergoline) and B (Bromocriptine), and were given standard doses of both drugs. The duration for restoration of menstruation, spontaneous conception, and outcomes of pregnancy were recorded over a period of 1 year in relation to the serum prolactin level estimations. Results: Most of the females were 25-30 years of age and most of them (98.2%) presented with amenorrhea. Restoration of menstruation was found to be earlier in group A, i.e., 3.6 months, as compared to group B, i.e., 5.8 months. Spontaneous conception within 6 months was observed in 42.6% of the patients of group A as compared to group B (26.8%). The rate of miscarriage was comparable in both groups. The live birth rate in the Cabergoline and Bromocriptine groups was 84% and 73.4%, respectively (p = 0.02). Mode of delivery was Caesarean section in both groups in all participants. Serum prolactin levels were significantly reduced in the Cabergoline group as compared to the Bromocriptine group (p = 0.035). Conclusion: Cabergoline is an effective drug for spontaneous conception within 6 months of successful restoration of menstruation in female patients with prolactinomas. Live birth rate is also higher in the Cabergoline group as compared to the Bromocriptine group.
AbstractList Background and objective: Prolactinoma is an uncommon cause of amenorrhea and subfertility in females. When diagnosed, symptoms resolve with medical treatment in 90% of the cases. Conception and uneventful pregnancy, however, remain a big challenge in these patients. The objective of this study was to determine the therapeutic effectiveness of Cabergoline for conception in female patients with prolactinoma. The duration for restoration of menstruation, spontaneous conception, and outcomes of pregnancy were recorded over a period of 1 year in relation to prolactin level estimation. Methods: This prospective study was carried over a period of 2 years from December, 2019 to December, 2021. A total of 696 female patients of reproductive age, diagnosed with prolactinomas, were included and randomly divided into 2 groups; A (Cabergoline) and B (Bromocriptine), and were given standard doses of both drugs. The duration for restoration of menstruation, spontaneous conception, and outcomes of pregnancy were recorded over a period of 1 year in relation to the serum prolactin level estimations. Results: Most of the females were 25-30 years of age and most of them (98.2%) presented with amenorrhea. Restoration of menstruation was found to be earlier in group A, i.e., 3.6 months, as compared to group B, i.e., 5.8 months. Spontaneous conception within 6 months was observed in 42.6% of the patients of group A as compared to group B (26.8%). The rate of miscarriage was comparable in both groups. The live birth rate in the Cabergoline and Bromocriptine groups was 84% and 73.4%, respectively (p = 0.02). Mode of delivery was Caesarean section in both groups in all participants. Serum prolactin levels were significantly reduced in the Cabergoline group as compared to the Bromocriptine group (p = 0.035). Conclusion: Cabergoline is an effective drug for spontaneous conception within 6 months of successful restoration of menstruation in female patients with prolactinomas. Live birth rate is also higher in the Cabergoline group as compared to the Bromocriptine group.
Author Zahra Safdar
Rabia Nafees
Omair Afzal
Nabeel Choudhary
Author_xml – sequence: 1
  fullname: Zahra Safdar
  organization: Assistant Professor, Department of Obstetrics & Gynecology, Central Park Medical College, Kasur, Pakistan
– sequence: 2
  fullname: Omair Afzal
  organization: Senior Registrar, Pakistan Institute of Neurosurgery (PINS), Lahore General Hospital, Lahore, Pakistan
– sequence: 3
  fullname: Rabia Nafees
  organization: Assistant Professor, Department of Obstetrics & Gynecology, Lahore General Hospital, Lahore, Pakistan
– sequence: 4
  fullname: Nabeel Choudhary
  organization: Assistant Professor, Department of Neurosurgery, Allama Iqbal Medical College/Jinnah Hospital, Lahore, Pakistan
BookMark eNotjE1LAzEUAIPooVbvHvMH1r587sabLWoLFS96Xl6SlxLZJiUugv9eUU8DwzCX7LzUQozdCLg1QmuxWuf6TDEHXJmuN3DGFrIX0CndiwVbb9BTO9QpF7rjWDilRGHOn8TnRjgfqcw81cZDLYFOc66F58JPrU74k5V6xCt2kXD6oOt_Ltnb48PrZtvtX552m_t9FwT0pnMkYhIEwlvtBHhppAMDoU8pDdIbCugkhkTWAgSMVmkF0QShB2fjINWS7f6-seL7eGr5iO1rrJjHX1HbYcQ25zDRaBQop9ErikYbGzxYI4fkDCgZPRj1DULPVuM
ContentType Journal Article
DBID DOA
DOI 10.51441/BioMedica/5-750
DatabaseName Directory of Open Access Journals
DatabaseTitleList
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
EISSN 2710-3471
EndPage 166
ExternalDocumentID oai_doaj_org_article_530394ab3ed5456cb06528f95032db05
GroupedDBID GROUPED_DOAJ
ID FETCH-LOGICAL-c1075-9e1df1e01b64910b2529050c7fff82b5eca92acfe6600cad63430d5c14896d823
IEDL.DBID DOA
IngestDate Tue Oct 22 15:15:22 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1075-9e1df1e01b64910b2529050c7fff82b5eca92acfe6600cad63430d5c14896d823
OpenAccessLink https://doaj.org/article/530394ab3ed5456cb06528f95032db05
PageCount 4
ParticipantIDs doaj_primary_oai_doaj_org_article_530394ab3ed5456cb06528f95032db05
PublicationCentury 2000
PublicationDate 2022-09-30
PublicationDateYYYYMMDD 2022-09-30
PublicationDate_xml – month: 09
  year: 2022
  text: 2022-09-30
  day: 30
PublicationDecade 2020
PublicationTitle BioMedica
PublicationYear 2022
Publisher Discover STM Publishing Ltd
Publisher_xml – name: Discover STM Publishing Ltd
Score 1.8592908
Snippet Background and objective: Prolactinoma is an uncommon cause of amenorrhea and subfertility in females. When diagnosed, symptoms resolve with medical treatment...
SourceID doaj
SourceType Open Website
StartPage 163
Title Cabergoline: an effective treatment for conception in prolactinoma
URI https://doaj.org/article/530394ab3ed5456cb06528f95032db05
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV09T8MwELWgEwsCAeJbHlijOufYjtloadWJBZDYIn9KSJAioP-fuziq2FhYPcTyi3Lvznn3jrGb2mgkdi8ro-m2CoLEb85TIqdCk3MGNwyDWT2ah5f2fkE2OdtRX6QJK_bABbipwhhrG-dlikT2wSNnQputEhKiH91LhS7FVPkPqahImJZLUjzpVFWG2up_efIP5LE8YPtj1sfvym6HbCf1R2w2dySuoqk56Za7nhdtBYYfvpV_c8wpeSithYggf-05hrw36kbo1-_umD0vF0_zVTWONKgC1lmqsqmOuU6i9rpBovagwAolgkFYWvAqBWfBhZw0JiLBRS0bKaIKWLRYHVuQJ2zSr_t0yniAKCGAbWtyW8iGnM1cm4SKyjkj4hmb0YG7j-Ja0ZGP9LCA6HYjut1f6J7_x0Mu2B5Q08Cgsrhkk-_PTbpiu19xcz28tR-Kkpyc
link.rule.ids 315,782,786,866,2106,27933,27934
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cabergoline%3A+an+effective+treatment+for+conception+in+prolactinoma&rft.jtitle=BioMedica&rft.au=Zahra+Safdar&rft.au=Omair+Afzal&rft.au=Rabia+Nafees&rft.au=Nabeel+Choudhary&rft.date=2022-09-30&rft.pub=Discover+STM+Publishing+Ltd&rft.eissn=2710-3471&rft.volume=38&rft.issue=3&rft.spage=163&rft.epage=166&rft_id=info:doi/10.51441%2FBioMedica%2F5-750&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_530394ab3ed5456cb06528f95032db05